Prostate Cancer Reports


Volume 1 Number 7
 July 2013

Home > Prostate Cancer Reports > Volume 1 - Year 2013 > Number 7, July 2013

CONTENTS


Topics
Localized PCa



TOPICS

Metastasis

Ho CC, Seong PK, Zainuddin ZM, Abdul Manaf MR, Parameswaran M, Razack AH.
Retrospective study of predictors of bone metastasis in prostate cancer cases.
Asian Pac J Cancer Prev. 2013;14(5):3289-92.
Abstract | Full text | Related citations


Nomograms

Teeter AE, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ.
Do Nomograms Designed to Predict Biochemical Recurrence (BCR) Do a Better Job of Predicting More Clinically Relevant Prostate Cancer Outcomes than BCR? A Report from the SEARCH Database Group.
Urology. 2013 Jul;82(1):53-9. doi: 10.1016/j.urology.2012.10.090.
Abstract | Related citations


Nutrition

Chua ME, Sio MC, Sorongon MC, Morales ML Jr.
The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis.
Can Urol Assoc J. 2013 May;7(5-6):E333-43. doi: 10.5489/cuaj.1056.
Abstract | Full text | Related citations


Prostate-specific antigen

Printz C.
Change in PSA levels over time can predict aggressive prostate cancer.
Cancer. 2013 Jun 15;119(12):2203-5.

Abstract | Full text |
Related Articles


Recurrence

Narita S, Mitsuzuka K, Yoneyama T, Tsuchiya N, Koie T, Kakoi N, Kawamura S, Kaiho Y, Ohyama C, Tochigi T, Yamaguchi T, Habuchi T, Arai Y.
Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy.
Prostate Cancer Prostatic Dis. 2013 Jun 11. doi: 10.1038/pcan.2013.16. [Epub ahead of print]
Abstract | Related citations


Survival

Chowdhury S, Robinson D, Cahill D, Rodriguez-Vida A, Holmberg L, Møller H.
Causes of death in men with prostate cancer: an analysis of 50 000 men from the Thames Cancer Registry.
BJU Int. 2013 Jul;112(2):182-9. doi: 10.1111/bju.12212.
Abstract | Related citations


Ito Y, Nakayama T, Miyashiro I, Ioka A, Tsukuma H.
Conditional survival for longer-term survivors from 2000-2004 using population-based cancer registry data in Osaka, Japan.
BMC Cancer. 2013 Jun 22;13:304. doi: 10.1186/1471-2407-13-304.
Abstract | Full text | Related citations


Treatment comparison


Asimakopoulos AD, Miano R, Di Lorenzo N, Spera E, Vespasiani G, Mugnier C.
Laparoscopic versus robot-assisted bilateral nerve-sparing radical prostatectomy: comparison of pentafecta rates for a single surgeon.
Surg Endosc. 2013 Jun 27. [Epub ahead of print]
Abstract | Related citations


Borregales LD, Berg WT, Tal O, Wambi C, Kaufman S, Gaya JM, Urzúa C, Badani KK.
'Trifecta' after radical prostatectomy: is there a standard definition?
BJU Int. 2013 Jul;112(1):60-7. doi: 10.1111/bju.12002.
Abstract | Related citations

LOCALIZED PROSTATE CANCER


Recurrence

Viriyasiripong S, Akarasakul D, Thaidamrong T, Doungkae S.
Predicting factors for biochemical recurrence and oncological outcomes following laparoscopic radical prostatectomy in Rajavithi Hospital, Thailand.
J Med Assoc Thai. 2013 May;96(5):569-74.
Abstract | Related citations


Zaorsky NG, Raj GV, Trabulsi EJ, Lin J, Den RB.
The dilemma of a rising prostate-specific antigen level after local therapy: what are our options?
Semin Oncol. 2013 Jun;40(3):322-36. doi: 10.1053/j.seminoncol.2013.04.011.
Abstract | Related citations


Survival

Arceo-Olaiz R, de Anda-González J, Urbina-Ramírez S, Sotomayor de Zavaleta M, Castillejos-Molina R, Gabilondo-Navarro F, Feria-Bernal G, Rodríguez-Covarrubias F.
[Positive surgical margins decrease cancer-specific survival of patients with prostate cancer treated with radical prostatectomy].
Gac Med Mex. 2013 May-Jun;149(3):286-91. Spanish
Abstract | Full text | Related citations


Treatment

Carthon BC, Marcus DM, Herrel LA, Jani AB, Rossi PJ, Canter DJ.
Therapeutic options for a rising PSA after radical prostatectomy.
Can J Urol. 2013 Jun;20(3):6748-55.
Abstract | Full text | Related citations


Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA.
Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation.
Cancer. 2013 Jun 24. doi: 10.1002/cncr.28213. [Epub ahead of print]
Abstract | Related citations


Valerio M, Ahmed HU, Emberton M, Lawrentschuk N, Lazzeri M, Montironi R, Nguyen PL, Trachtenberg J, Polascik TJ.
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review.
Eur Urol. 2013 Jun 6. doi:pii: S0302-2838(13)00557-5. 10.1016/j.eururo.2013.05.048. [Epub ahead of print]
Abstract | Related citations


Zaorsky NG, Trabulsi EJ, Lin J, Den RB.
Multimodality therapy for patients with high-risk prostate cancer: current status and future directions.
Semin Oncol. 2013 Jun;40(3):308-21. doi: 10.1053/j.seminoncol.2013.04.006.
Abstract | Related citations


Treatment comparison

Shao YH, Kim S, Moore DF, Shih W, Lin Y, Stein M, Kim IY, Lu-Yao GL.
Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis.
Eur Urol. 2013 May 21. doi:pii: S0302-2838(13)00489-2. 10.1016/j.eururo.2013.05.023. [Epub ahead of print]
Abstract | Related citations